Inhibitors of G-protein-coupled estrogen receptor (GPER1) that have been characterized could be used to treat or prevent liver cancer (Park et al., 2010; Chaturantabut et al., 2019; Jindal et al., 2019). The gene discussed is GPER1; the disease is liver cancer.